Primary care-based melanoma screening is associated with increased detection of thin melanomas, according to a study published online April 6 in JAMA Dermatology.
Apr 06, 2022
0
4
For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...
Mar 21, 2022
0
13
For years, surgery for patients with stage III melanoma—melanoma that has spread to the lymph nodes—involved removing those lymph nodes along with the primary tumor. Known as completion lymph node dissection (CLND), the ...
Mar 04, 2022
0
4
Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering ...
Feb 28, 2022
0
142
Many melanoma patients are treated with drugs called BRAF or MEK inhibitors that specifically target the mutant proteins created in cancerous tumors. These inhibitors can block the tumors' ability to grow and spread.
Feb 28, 2022
0
52
A diet rich in fiber may help some people being treated for melanoma respond to immunotherapy treatment by influencing the gut microbiome, according to a new study led by researchers at the Center for Cancer Research at the ...
Dec 23, 2021
0
136
Melanoma patients using their smart phone to submit images of lesions to their specialists appears to be a safe and convenient form of follow-up after treatment.
Nov 25, 2021
0
48
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman ...
Sep 20, 2021
0
0
Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as well to an investigational therapy that involves the adoptive cell transfer of tumor-infiltrating lymphocytes ...
Aug 19, 2021
0
47
A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research.
Jul 27, 2021
0
88
